A carregar...
Azithromycin and the microbiota of cystic fibrosis sputum
BACKGROUND: Azithromycin is commonly prescribed drug for individuals with cystic fibrosis (CF), with demonstrated benefits in reducing lung function decline, exacerbation occurrence and improving nutrition. As azithromycin has antimicrobial activity against components of the uncultured microbiome an...
Na minha lista:
| Publicado no: | BMC Microbiol |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BioMed Central
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8008652/ https://ncbi.nlm.nih.gov/pubmed/33784986 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12866-021-02159-5 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|